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The serum concentrations of some acute phase proteins were determined on
admission, during treatment, at the end of treatment and at 12 months after
s topping t reatment  in  20 pat ients  with pulmonary tuberculosis .
Measurements were also made, on admission and at the end of treatment, in
19 patients with abdominal tuberculosis, and 11 children with tuberculous
meningitis. All 20 patients with pulmonary TB had quiescent disease by the
end of treatment and none had a bacteriological relapse during the follow-
up period of 12 months. The response to treatment was considered
favorable in 18 of the 19 patients with abdominal TB, and the CSF findings
had returned to normal in 9 of 11 patients with TB meningitis. There was a
significant decrease with treatment in the concentrations of C-reactive
protein, ceruloplasmin, haptoglobin and a1 -acid glycoprotein in all 3 groups
of patients. While there was an increase in the concentrations of transferrin
in patients with pulmonary and abdominal TB, there was a significant
decrease in those with TB meningitis, a2- macroglobulin did not appear to
function as an acute phase reactant in any of the 3 groups. Amalgamating
the findings in all 3 groups of tuberculous patients, the proportions of
patients with abnormal values on admission and at the end of treatment
were 62% and 14% for C-reactive protein, 78% and 50% for ceruloplasmin,
86% and 26% for haptoglobin and 92% and 6% for a1- acid glycoprotein,
respectively.
The immediate local response to tissue injury or infection is acute inflammation
resulting in a number of systemic, metabolic and physiologic alterations, the event being
referred to as the acute phase response. The acute phase reaction is accompanied by
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changes in the concentrations of several plasma proteins mainly of hepatic origin, referred
to as acute phase proteins. A marked increase ranging from about 50% as with
ceruloplasmin to several hundred-fold as with C-reactive protein and serum amyloid-A-
protein is observed with some proteins, in contrast, the concentrations of some proteins
such as albumin and transferrin have been found to decrease during the acute phase
response1. While the concentrations of some of these proteins have been reported in
patients with pulmonary tuberculosis and tuberculous pleural effusior2,3, little or no
information is available in those with extra-pulmonary forms of the disease.
The serum concentrations of some of these proteins, notably C-reactive protein, have
been used to assess the severity of several acute bacterial diseases, myocardial infarction
and rheumatoid arthritis, and also to monitor the progress of these patients during
treatment4,5. The elevation in the erythrocyte sedimentation rate and the serum
concentration of the a2- globulin fraction, both measures of acute phase response involving
a rise in the concentrations of several plasma proteins, have been used without much
success to assess the activity of disease and also to predict a bacteriological relapse which
occurs in a proportion of patients with pulmonary tuberculosis after stopping treatment.6,7
It is possible that concentrations of some individual proteins might be better indicators of
the activity of the disease. Further, identification of a protein whose serum concentration at
the end of treatment can predict a bacteriological relapse would be of immense value. A
prelimnary investigation was, therefore, undertaken to compare the serum concentrations
of some acute phase proteins in patients with pulmonary, and abdominal tuberculosis and
tuberculous meningitis with those in healthy volunteers, and also to study the changes. in
the concentrations of these proteins during treatment with anti-tuberculosis drugs, to
identify the proteins that could subsequently be studied in greater detail for assessment and
predictive purposes.
Material and Methods
The acute phase proteins. investigated were C-reactive protein, ceruloplasmin,
haptoglobin, a1 -acid glycoprotein, transferrin and a2 -macroglobulin.
These investigations were undertaken in South Indian patients admitted to controlled
clinical trials of pulmonary tuberculosis, abdominal tuberculosis and tuberculous
meningitis conducted at this Centre. Blood samples were collected from these patients at
different time-points, and serum separated and stored at –20 °C till the concentrations of
the acute phase proteins were determined.
Subjects
Pulmonary tuberculosis. Twenty consecutive patients admitted to a trial of the treatment
of pulmonary tuberculosis with fully intermittent short-course regimens containing
rifampicin, isoniazid, streptomycin and pyrazinamide were included in the present study.
All the patients were aged 12 years or more and the disease was diagnosed on the basis of
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the results of direct smear and culture examination of sputum. Blood samples were
collected on admission (0 month), during treatment (2 months), at the end of treatment (6
months) and also at 18 months i.e., 12 months after stopping treatment). All these patients
had attained bacteriological quiescence at the end of treatment and none had a
bacteriological relapse during a follow-up period of 12 months after stopping
chemotherapy.
Abdominal tuberculosis. Nineteen patients were included in this study. Of these, 10 were
randomly allocated to a short-course regimen of rifampicin, isoniazid and streptomycin for
6 months and the remaining 9 to a standard regimen of streptomycin, isoniazid and
ethambutol for a period of 12 months. All the patients were aged 12 years or more and the
disease was diagnosed on the basis of histopathological, radiological or bacteriological
findings. Blood samples from these patients were collected at the time of admission and at
the end of chemotherapy (6/12 months). Of the 19 patients admitted, 18 were considered
to have had a favourable response to treatment at the end of treatment.
Tuberculous meningitis. Eleven consecutive patients (1 in Stage I and 10 in Stage II),
treated with short-course regimens of rifampicin, isoniazid, streptomycin, ethambutol and
pyrazinamide of 9 months duration, were included in thisstudy. The patients were aged 1-
12 years and the diagnosis of tuberculous meningitis in these patients was based on clinical
and CSF findings; blood samples were collected on admission and at the end of
chemotherapy (9 months). At the end of treatment, the CSF findings were normal in 9 of
the 11 patients; the recovery was complete in 4 patients while the rest had residual
neurological sequelae (mild in 3, moderate in 3 and severe in 1).
Healthy volunteers were from laboratory staff working at this Centre and were aged 20
years or more.
The standards, antisera and the control specimens of the acute phase proteins were
purchased from Behringwerke AG, West Germany.
Assay procedure. The concentrations of the acute phase proteins in the serum samples
were estimated using the radial immunodiffusion technique employing the specific antisera
and a minimum of 4 standards8. The assays were undertaken in batches; each batch had
samples in duplicate from the different groups of subjects in addition to the standards. All
assays were undertaken after randomising the samples and standards.
Results
Preliminary investigations (data not tabulated) had shown that the regression of the
square of the diameters of the precipitin rings on the standard protein concentrations was
linear; the correlation co-efficients ranged from 0.989 to 0.999 for different proteins.
Variation between replicates within the plate was not significant (p > 0.2), and the mean
co-efficient of variation for estimates obtained on two different occasions ranged from
2.1% with C-reactive protein to 10.4% with ceruloplasmin. While the differences between
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the mean concentrations on two separate occasions were not significant for C-reactive
protein, haptoglobin a2 -acid glycoprotein and a2 -macroglobulin (p > 0.1), those for
transferrin (p < 0.05) and ceruloplasmin (p < 0.03) were statistically significant.
The mean serum concentrations on admission in patients with pulmonary and
abdominal tuberculosis and tuberculous meningitis and rose in healthy volunteers
together with the normal range9 are presented in table 1. In the 11 healthy subjects, the
values were within the normal range9 in all for ceruloplasmin, in 10 for C-reactive protein,
in 9 each for a1 -acid glycoprotein and a2 -macroglobulin, in 8 for haptoglobin and in 7 for
transferrin.
Table 1. Serum acute phase protein concentrations in tuberculous patients and healthy volunteers
Acute phase protein Mean and standard deviation of serum concentrations (mg/dl)
Pulmonary Abdominal Meningeal Healthy Normal
TB TB TB volunteers range
C-reactive protein 7.2 ± 6.2 2.1 ± 2.3 1.1 ± 1.1 0.15 ± 0.27 0.01-0.8
Ceruloplasmin 76 ± 23 63 ± 29 78 ± 65 25 ± 5 15-45
Haptoglobin 512 ± 163 309 ± 162 509 ± 163 146 ± 77 40-180
a1 -acid glycoprotein 269 ± 87 246 ± 90 245 ± 107 61 ± 23 35-140
Transferrin
a2 -macroglobulin
228 ± 55 229 ± 78 410 ± 125 339 ± 68 200-340
310 ± 93 296 ± 104 491 ± 141 275 ± 112 Adults : 150-350
No. of subjects 20 19 11 11 Children : > 400
* Quoted from reference9.
The mean concentrations of C-reactive protein, ceruloplasmin, haptoglobin and a1 -acid
glycoprotein were significantly higher in all 3 groups of tuberculous patients than in healthy
volunteers (p < 0.001). The mean transferrin concentrations in patients with pulmonary
and abdominal tuberculosis were significantly lower than in healthy volunteers (p < 0.01);
in patients with tuberculous meningitis, however, these levels were higher than in the
healthy subjects (p < 0.01). The mean concentrations of a2 -macroglobulin were similar in
pulmonary and abdominal tuberculous patients and healthy volunteers. The concentration
of this protein in children is reported to be higher than in adults9, and 9 of the 11 children
with tuberculous meningitis had values greater than 400 mg/dl. Comparing the values
between the 3 groups of tuberculous patients, the mean value for C-reactive protein in
patients with pulmonary tuberculosis was significantly higher than in patients with
abdominal tuberculosis or tuberculous meningitis (p < 0.01 for both), while the mean value
of haptoglobin in patients with abdominal tuberculosis was lower than those in the other
two groups (p < 0.01 for both), the mean value for transferrin was higher in patients with
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tuberculous meningitis than in the other two groups (p < 0.01). The differences between
the mean concentrations in the other proteins were not significant with the exception of a2-
macroglobulin; the mean concentration of this protein was significantly higher in children
with tuberculous meningitis than in the other two groups (p < 0.01).
The mean concentrations of the different proteins at 0, 2, 6 and 18 months in patients
with pulmonary tuberculosis are presented in Table 2. There was a sharp decrease in the
mean concentrations of C-reactive protein, haptoglobin and a1 -acid glycoprotein with
treatment and the mean values both at 2 months and at the end of chemotherapy were
appreciably lower than the values on admission (p < 0.01 for all). The mean values of these
Table 2. Serial serum acute phase protein concentrations in patients treated for pulmonary tuberculosis
Acute phase protein Mean and standard deviation of serum concentrations (mg/dl)
0 month 2 months 6 months* 18 months**
C-reactive protein 7.2 ± 6.2 2.2 ± 2.4 0.8 ± 2.8 0.7 ± 1.4
Ceruloplasmin 76 ± 23 79 ± 48 60 ± 19 29 ± 8
Haptoglobin 512 ± 163 278 ± 159 152 ± 92 160 ± 94
a1 -acid glycoprotein 269 ± 87 166 ± 76 86 ± 31 90 ± 45
Transferrin 228 ± 55 342 ± 133 332 ± 81 290 ± 51
a2 -macroglobulin 310 ± 93 362 ± 149 346 ± 117 350 ± 102
* End of chemotherapy
** 12 month after stopping treatment
three proteins at 18 month (i.e., 12 months after stopping treatment) were similar to those
at the end of treatment. The mean values of ceruloplasmin were similar at 0 and 2 months;
there was a slight but significant fall by the end of chemotherapy (p < 0.05), and the mean
value at 18 month was appreciably lower than that at the end of chemotherapy (p < 0.01).
There was a significant increase in the mean concentration of transferrin with treatment
(p < 0.01); however, there was a slight fall thereafter, and the mean value at 18 month was
significantly lower than that at the end of chemotherapy (p < 0.01). The differences
between the mean concentrations of a2 -macroglobulin at the four different time-points
were not significant (p > 0.2).
The mean concentrations of the acute phase proteins on admission and at the end of
treatment in patients with abdominal tuberculosis and tuberculous meningitis are
presented in Table 3 (The findings in patients with abdominal tuberculosis who received
treatment for 6 or 12 months were similar and have therefore been amalgamated). In
patients with abdominal tuberculosis there was a significant decrease in the concentrations
of C-reactive protein, ceruloplasmin, haptoglobin and a1 -acid glycoprotein (p < 0.05) and a
significant increase in that of transferrin (p < 0.01) with treatment. The increase in the
concentration of α2 -macroglobulin was not significant (p > 0.2).
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Table 3. Serum acute phase protein concentrations on admission and at the end of treatment in
patients with abdominal tuberculosis and tuberculous meningitis
Acute phase protein Mean and standard deviation of serum concentrations (mg/dl)
Abdominal TB TB Meningitis
0  m 6/12 m 0 m 9  m
C-reactive protein 2.1 ± 2.3 0.8 ± 1.8 1.1 ± 1.1 0.2 ± 0.2
Ceruloplasmin 63 ± 29 40 ± 33 78 ± 65 41 ± 14
Haptoglobin 309 ± 162 119 ± 85 509 ± 163 154 ± 87
a1 acid glycoprotein 246 ± 90 78 ± 42 245 ± 107 97 ± 28
Transferring 229 ± 78 291 ± 68 410 ± 125 234 ± 56
a2 macroglobulin 296 ± 104 346 ± 106 491 ± 141 502 ± 118
In patients with tuberculous meningitis, with the exception of a2 -macroglobulin, there
was a significant decrease in the levels of all acute phase proteins including that of
transferrin with treatment (p < 0.01 for all).
The number of patients with abnormal values on admission and at the end of treatment
are presented in Table 4 (The figures for a2 -macroglobulin have not been presented as this
protein did not appear to behave like an acute phase reactant in any of the 3 groups).
Amalgamating the findings in all 3 groups of tuberculous patients, the values were
abnormal on admission in 62% of the 50 patients for C-reactive protein, 78% for
Table 4. Number of tuberculous patients with abnormal values for some acute phase proteins on







Pulmonary TB Abdominal TB TB meningitis
0 6 0 6/12 0 9
m o n t h  m o n t h s  m o n t h  m o n t h s  m o n t h  m o n t h s
C-reactive protein > 0.8 17 3 10 4 4 0
Ceruloplasmin > 45 20 15 12 4 7 6
Haptoglobin > 180 18 6 14 3 11 4
a1 -acid glycoprotein > 140 18 1 17 2 11 0
Transferrin < 200 6 0 5 2 0 0
No. of patients 20 19 11
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ceruloplasmin, 86% for haptoglobin and 92% for α1 -acid glycoprotein; the corresponding
proportions at the end of treatment were 14%, 50%, 26% and 6% respectively.
Discussion
Following stimulus through infection or injury, the macrophage releases a monokine,
interleukin 1, which stimulates the hepatocyte to secrete a number of acute phase
proteins10. These acute phase reactants have been shown to serve a variety of functional
roles during tissue repair of infection or inflammation and in several host immune-defence
mechanisms C-reactive protein has been shown to cause bacterial capsular swelling,
promotion of agglutination, complement fixation and enhancement of phagocytosis11.
Oxygen-derived free radicals and hydrogen peroxide produced by activated
polymorphonuclear leucocytes, are believed to be the important agents causing the death
of engulfed micro-organisms12,13,and also to be the cause of inflammation and tissue
injury14. Increased concentrations of ceruloplasmin, known to possess significant oxidase
activity and capable of scavenging oxygen-derived free radicals14,15,are probably responsible
for limiting the damage caused by these radicals. Haptoglobin and transferrin have been
shown to play important roles in restricting the availability of iron, an essential nutrient for
the survival and proliferation of micro-organisms within the host16. Haptoglobin binds
hemoglobin which is known to support bacterial growth16,17, and transferrin binds free iron
available within the cell18. The decrease in transferrin concentrations during the acute
phase reaction is attributed to an excess of catabolism over synthesis16. While transferrin
concentrations increased with treatment in patients with pulmonary, and abdominal
tuberculosis, a decrease was observed in all patients with tuberculous meningitis. The
significance of this finding needs to be evaluated further. The precise role of α1 -acid
glycoprotein in human immune-defence mechanisms is not clear, though it is believed to
serve as a T-cell mediator19. α2 -macroglobulin did not appear to function as an acute phase
reactant in our patients, and this is in agreement with findings reported earlier20.
A bacteriological relapse requiring treatment is known to occur in a proportion of
patients with pulmonary tuberculosis who have quiescent disease at the end of treatment21.
Investigations undertaken earlier at our Centre had shown that the mean serum
concentration of the α2 -globulin fraction at the end of treatment was significantly higher in
patients who relapsed subsequently than in those who did not; it was however not possible
to suggest the level of the concentration at which the outcome of a relapse could be
predicted7. The erythrocyte sedimentation rate, which is also a measure of acute phase
response, is not a suitable marker as it was found to be elevated in a substantial proportion
of patients who had attained stable bacteriological quiescence after treatment6. It has been
suggested that an elevated concentration of C-reactive protein is unequivocal evidence of
an active tissue-damaging process1,22 , however, even this protein may not be suitable as its
concentration at the end of treatment was found elevated in 3 of the 20 patients with
pulmonary tuberculosis, none of whom relapsed during a follow-up period of 12 months.
Ceruloplasmin and haptoglobin concentrations at the end of treatment were elevated in too
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high a proportion of patients to merit their use for predictive purposes. Of all the proteins
investigated, only a1 -acid glycoprotein seemed to hold some promise as its concentrations
were elevated in 90% of patients with pulmonary tuberculosis on admission, and only one
of these had an abnormal value at the end of the scheduled period of chemotherapy.
Whether elevated concentrations of this protein reflect the extent of tuberculous lesion
before start of treatment, and whether its concentration at the end of treatment (either
alone or in combination with other proteins) can predict a bacteriological relapse needs to
be investigated in a much larger group of patients, and a prospective study is in progress at
our Centre.
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